Diagnóstico de schwannomatosis relacionada con NF2
Children's Tumor Foundation | 2024
Visit WebsiteChildren's Tumor Foundation | 2024
Visit WebsiteRecursion Pharmaceuticals Inc.
This is a parallel-group, two-staged, Phase 2/3, randomized, multi-center study to investigate the efficacy and safety of REC-2282 in patients…
View ArticleChildren's Tumor Foundation | 2023
Visit WebsiteChildren's Tumor Foundation | 2021
Visit WebsiteChildren's Tumor Foundation | 2020
Visit WebsiteChildren's Tumor Foundation | 2023
Visit Website
University of Wisconsin-Milwaukee
| 2023
By Dr. Bonnie Klein-Tasman
Children's Tumor Foundation | 2023
Visit WebsiteBy NF Midwest
Visit WebsiteMass General Brigham | 2023
We want to learn more about your experiences looking for NF1 medical information and healthcare. We will use this information…
View Article
© 2024 Neurofibromatosis Midwest - non profit 501(c)(t3). Site Map - Privacy Policy
The resources on this site should not be used as a substitute for professional medical care or advice on Neurofibromatosis. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional.